NCT03023449View on ClinicalTrials.gov

Diffuse Optical Monitoring With Inhaled Nitric Oxide

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

April 4, 2017

Primary Completion Date

March 21, 2021

Study Completion Date

July 31, 2026

Conditions
Stroke
Interventions
DRUG

Nitric Oxide

Inhaled Nitric Oxide gas

Trial Locations (1)

19104

Hospital of the University of Pennsylvania, Philadelphia

Sponsors

Collaborators (1)

Mallinckrodt
All Listed Sponsors
collaborator

Mallinckrodt

INDUSTRY

lead

Steven Messe

OTHER

NCT03023449 - Diffuse Optical Monitoring With Inhaled Nitric Oxide | Biotech Hunter | Biotech Hunter